MEND Innovation & Translation Alliance Management (MITAM)

MITAM’s primary mission is to provide a nexus where the most promising advanced technologies can be vetted against the most daunting issues confronting vaccine & drug candidates for diseases of poverty, and yield solutions to allow real products to get to market.

The initiative’s primary goals are to:

• Create and maintain a networked community of pharmaceutical scientists, engineers, and others, from industry and academia, involved in the development and implementation of advanced delivery technology.
• Maintain a scientific advisory board, with majority membership from developing countries, to evaluate potential applications of advanced delivery technologies and vaccine candidates
• Identify the most daunting hurdles to the development of existing vaccine/therapeutic candidates for the primary diseases of poverty (HIV, Malaria, TB), as well as other neglected tropical diseases.
• Unite the delivery technology community together with the vaccine/therapy researchers to:
  • participate in regular, creative innovation colloquia in order to generate new thinking and approaches
  • propose solutions to the hurdles, and fund those solutions through feasibility and/or preclinical